Advanced in Disseminated Intravascular Coagulation

Naoki Fujita

Hirosaki, JP 
Advanced in Disseminated Intravascular Coagulation
Hirosaki, JP 
OverviewLocationsClinical Research

Overview

Naoki Fujita practices in Hirosaki, Japan. Mr. Fujita is rated as an Advanced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. His top areas of expertise are Bladder Cancer, Erectile Dysfunction (ED), Sepsis, Cystectomy, and Nephrectomy.

His clinical research consists of co-authoring 103 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Disseminated Intravascular Coagulation.

Gender
Male

Locations

Hirosaki, 0368562, Japan
Other Locations
Tokyo, 1130032, Japan
Yayoi, 1138657, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3

103 Total Publications

Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer.
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer.
Journal: International journal of clinical oncology
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fujita's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile